Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $72.9 million versus the consensus estimate of $68.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.